Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$248.2M
+77.3% from 2023
Prescriptions
1.1M
$216.33 per claim
Patients
400K
172,551 prescribers
Total spending, 2024
$248.2M
$620.91 per patient
Medicare prescription drug plans paid $248.2M for Budesonide-Formoterol Fumarate in 2024, for 1,147,155 prescriptions and refills to 399,646 patients (up 77.3% from 2023). The average cost per claim was $216.33.
New York had the highest Medicare cost for Budesonide-Formoterol Fumarate in 2024: $22.7M for 105,926 claims, followed by Michigan ($18.4M).
Jahaira L Serrano Dominguez, pulmonary disease in Arecibo, PR, had the highest Medicare cost for Budesonide-Formoterol Fumarate in 2024: 1,495 claims costing $409K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 1,495 | 320 | $409K |
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 2,181 | 506 | $352K |
| Samuel A Amill-Acosta |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 111,483 | 416,201 | 210,719 | $140.9M |
| 2023 | 118,546 | 432,301 | 224,218 | $140.0M |
| 2024 | 172,551 | 1,147,155 | 399,646 | $248.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 1,102 |
| 321 |
| $296K |
| Ppluis Echegaray Guaynabo, PR | Internal Medicine | 921 | 322 | $224K |
| Jesus M Roman Mayaguez, PR | Pulmonary Disease | 747 | 183 | $207K |
| Rosa I Roman Carlo Mayaguez, PR | Pulmonary Disease | 754 | 152 | $202K |
| Armando O Cardona-Ramirez Mayaguez, PR | Pulmonary Disease | 652 | 153 | $181K |
| Mildred Caro Ruiz Aguada, PR | Pulmonary Disease | 650 | 161 | $180K |
| Maria del Mar Torres-Perez San German, PR | Pulmonary Disease | 630 | 141 | $171K |
| Luis A de Jesus Vargas Caguas, PR | Pulmonary Disease | 584 | 219 | $152K |
| Nestor J Flores Guayama, PR | Pulmonary Disease | 537 | 151 | $147K |
| Raul A Rios Mollineda Bayamon, PR | Pulmonary Disease | 591 | 185 | $147K |
| Francisco E Carro Anzalota Bayamon, PR | Pulmonary Disease | 572 | 156 | $144K |
| Oscar Rivera Caguas, PR | Pulmonary Disease | 527 | 122 | $133K |
| William Villanueva-Bosque Arecibo, PR | Pulmonary Disease | 507 | 126 | $131K |
| Antonio M Padua-Ramos Mayaguez, PR | Pulmonary Disease | 451 | 125 | $130K |
| Andres D Bermudez Caba Coto Laurel, PR | Pulmonary Disease | 450 | 121 | $119K |
| Adriana Candelario-Gonzalez Caguas, PR | Pulmonary Disease | 476 | 126 | $110K |
| Luis F Velez-Quinones Arecibo, PR | Internal Medicine | 446 | 102 | $109K |
| Hazen H Tuck Jr. Janesville, WI | Pulmonary Disease | 285 | 82 | $107K |
| Elsie M Diaz - Schroeder Caguas, PR | Pulmonary Disease | 410 | 83 | $107K |
| Francisco M Montalvo Mayaguez, PR | Pulmonary Disease | 378 | 76 | $104K |
| Ramon E Flores San Juan, PR | Pulmonary Disease | 392 | 137 | $100K |
| Ruben Rodriguez-Perez Sr. San Juan, PR | Pulmonary Disease | 357 | 85 | $95K |
| Hataya K Poonyagariyagorn Beaverton, OR | Pulmonary Disease | 327 | 80 | $94K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca/Pra | 1,147,488 | $248.2M |